R. Wise

1.9k total citations · 1 hit paper
52 papers, 1.5k citations indexed

About

R. Wise is a scholar working on Pharmacology, Molecular Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, R. Wise has authored 52 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pharmacology, 22 papers in Molecular Medicine and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in R. Wise's work include Antibiotics Pharmacokinetics and Efficacy (29 papers), Antibiotic Resistance in Bacteria (22 papers) and Atrial Fibrillation Management and Outcomes (7 papers). R. Wise is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (29 papers), Antibiotic Resistance in Bacteria (22 papers) and Atrial Fibrillation Management and Outcomes (7 papers). R. Wise collaborates with scholars based in United Kingdom, United States and Spain. R. Wise's co-authors include J. M. Andrews, Laura Edwards, N. Brenwald, I A Donovan, J. M. Andrews, Mark H. Eckman, Anthony C. Leonard, Faisal Khan, Eric J. Warm and J. P. Ashby and has published in prestigious journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and Journal of the American Geriatrics Society.

In The Last Decade

R. Wise

51 papers receiving 1.3k citations

Hit Papers

In vitro activity of Bay 09867, a new quinoline derivativ... 1983 2026 1997 2011 1983 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents
    1983 412 citations R. Wise, J. M. Andrews et al. Antimicrobial Agents and Chemotherapy profile →

Peers

R. Wise
D. S. Reeves United Kingdom
Ron E. Polk United States
Lavern M. Vercaigne Canada
B. Joseph Guglielmo United States
John E. Conte United States
Joseph A. Paladino United States
Lee B. Barradell
I. Nilsson-Ehle Sweden
C H Nightingale United States
J. Blaser Switzerland
D. S. Reeves United Kingdom
R. Wise
Citations per year, relative to R. Wise R. Wise (= 1×) peers D. S. Reeves

Countries citing papers authored by R. Wise

Since Specialization
Citations

This map shows the geographic impact of R. Wise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Wise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Wise more than expected).

Fields of papers citing papers by R. Wise

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Wise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Wise. The network helps show where R. Wise may publish in the future.

Co-authorship network of co-authors of R. Wise

This figure shows the co-authorship network connecting the top 25 collaborators of R. Wise. A scholar is included among the top collaborators of R. Wise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Wise. R. Wise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eckman, Mark H., R. Wise, Anthony C. Leonard, et al.. (2023). Can a best practice advisory improve anticoagulation prescribing to reduce stroke risk in patients with atrial fibrillation?. Journal of Cardiology. 83(5). 285–290. 1 indexed citations
2.
Eckman, Mark H., Alexandru Costea, Mehran Attari, et al.. (2018). Shared decision-making tool for thromboprophylaxis in atrial fibrillation – A feasibility study. American Heart Journal. 199. 13–21. 19 indexed citations
3.
Eckman, Mark H., R. Wise, Gregory Y.H. Lip, et al.. (2015). Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making. Current Medical Research and Opinion. 31(4). 603–614. 30 indexed citations
4.
Eckman, Mark H., R. Wise, Megan Sullivan, et al.. (2014). Integrating Real-Time Clinical Information to Provide Estimates of Net Clinical Benefit of Antithrombotic Therapy for Patients With Atrial Fibrillation. Circulation Cardiovascular Quality and Outcomes. 7(5). 680–686. 18 indexed citations
5.
Schauer, Daniel P., David Arterburn, R. Wise, et al.. (2013). Predictors of bariatric surgery among an interested population. Surgery for Obesity and Related Diseases. 10(3). 547–552. 11 indexed citations
6.
Eckman, Mark H., et al.. (2011). Impact of health literacy on outcomes and effectiveness of an educational intervention in patients with chronic diseases. Patient Education and Counseling. 87(2). 143–151. 114 indexed citations
7.
Arterburn, David, Daniel P. Schauer, R. Wise, et al.. (2008). Change in Predicted 10-Year Cardiovascular Risk Following Laparoscopic Roux-en-Y Gastric Bypass Surgery. Obesity Surgery. 19(2). 184–189. 45 indexed citations
8.
Thorp, Micah L., et al.. (2005). A study of the prevalence of significant increases in serum creatinine following angiotension-converting enzyme inhibitor administration. Journal of Human Hypertension. 19(5). 389–392. 8 indexed citations
9.
Boswell, F. J., J. M. Andrews, J. P. Ashby, et al.. (1998). The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent. Journal of Antimicrobial Chemotherapy. 42(6). 703–709. 61 indexed citations
10.
Andrews, J. M., et al.. (1997). A reassessment of the in-vitro activity of colistin sulphomethate sodium. Journal of Antimicrobial Chemotherapy. 39(2). 255–260. 122 indexed citations
11.
Andrews, J. M., et al.. (1994). The comparative pharmacokinetics and tissue penetration of single-dose ciprofloxacin 400 mg iv and 750 mg po. Journal of Antimicrobial Chemotherapy. 33(1). 103–110. 33 indexed citations
12.
Andrews, J. M., et al.. (1993). The in-vitro activity of a new highly active quinolone, DU-6859a. Journal of Antimicrobial Chemotherapy. 32(5). 757–763. 22 indexed citations
13.
Perry, Guy M. L., Tim Mant, P. J. Morrison, et al.. (1993). Pharmacokinetics of rufloxacin in patients with impaired renal function. Antimicrobial Agents and Chemotherapy. 37(4). 637–641. 10 indexed citations
14.
Wise, R., James Johnson, Niamh O’Sullivan, J. M. Andrews, & Bruno P. Imbimbo. (1991). Pharmacokinetics and tissue penetration of rufloxacin, a long acting quinolone antimicrobial agent. Journal of Antimicrobial Chemotherapy. 28(6). 905–909. 27 indexed citations
15.
Stone, JA, et al.. (1989). Cefixime, in-vitro activity, pharmacokinetics and tissue penetration. Journal of Antimicrobial Chemotherapy. 23(2). 221–228. 34 indexed citations
16.
Wise, R., et al.. (1988). The penetration of fleroxacin into bronchial mucosa. Journal of Antimicrobial Chemotherapy. 22(2). 203–206. 21 indexed citations
17.
Wise, R., et al.. (1988). The pharmacokinetics and tissue penetration of intravenously administered CGP 31608. Journal of Antimicrobial Chemotherapy. 21(1). 85–91. 3 indexed citations
18.
Phillips, Ian, R. Wise, & D. A. Leigh. (1983). Cefotetan: a new cephamycin.. PubMed. 11 Suppl. 1–239. 4 indexed citations
19.
Wise, R., et al.. (1979). Comparative in vitro microbiological activity and stability of cefaclor.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 55 Suppl 4. 9–11. 5 indexed citations
20.
Wise, R.. (1978). Use of antibiotics. Cephalosporins.. BMJ. 2(6129). 40–42. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. S. Reeves Breakdown of academic impact, for papers by Ron E. Polk Breakdown of academic impact, for papers by Lavern M. Vercaigne Breakdown of academic impact, for papers by B. Joseph Guglielmo Breakdown of academic impact, for papers by John E. Conte Breakdown of academic impact, for papers by Joseph A. Paladino Breakdown of academic impact, for papers by Lee B. Barradell Breakdown of academic impact, for papers by I. Nilsson-Ehle Breakdown of academic impact, for papers by C H Nightingale Breakdown of academic impact, for papers by J. Blaser
Rankless by CCL
2026